APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Discovery

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Drug Discovery Market Analysis and Forecast 2026-2032

Report ID 17405741024 June 2026237 pages

Choose your research edition.

Industry ResearchAI Drug Discovery Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Discovery Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal AI Drug Discovery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Discovery Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Discovery Market Analysis and Forecast 2026-2032237 pages · $4,950 USD

Market perspective

The global AI Drug Discovery market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Drug Discovery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Drug Discovery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Drug Discovery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Drug Discovery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Drug Discovery include Recursion, Insilico Medicine, Schrödinger, DeepMind, Insitro, Generate Biomedicines, XtalPi, Relay Therapeutics and BenevolentAI, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Drug Discovery, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Drug Discovery, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Drug Discovery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Drug Discovery revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Drug Discovery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Drug Discovery revenue, projected growth trends, production technology, application and end-user industry.

AI Drug Discovery Segment by Company

Recursion

Insilico Medicine

Schrödinger

DeepMind

Insitro

Generate Biomedicines

XtalPi

Relay Therapeutics

BenevolentAI

Roivant Sciences

Ginkgo Bioworks

Exscientia

Merck KGaA

Novartis

Biotus

Huazhi Bio

MindRank AI

Ubigene

WuXi AppTec

AI Drug Discovery Segment by Type

Machine Learning Type

Deep Learning Type

Natural Language Processing Type

Data Mining Type

AI Drug Discovery Segment by Application

Target Discovery and Validation

Virtual Screening and Molecular Docking

Drug Repurposing and Precision Medicine

Clinical Data Analysis and Optimization

AI Drug Discovery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Drug Discovery company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Discovery revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Drug Discovery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Machine Learning Type Major Player Table 3. Deep Learning Type Major Player Table 4. Natural Language Processing Type Major Player Table 5. Data Mining Type Major Player Table 6. Global AI Drug Discovery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Target Discovery and Validation Major Player Table 8. Virtual Screening and Molecular Docking Major Player Table 9. Drug Repurposing and Precision Medicine Major Player Table 10. Clinical Data Analysis and Optimization Major Player Table 11. AI Drug Discovery Industry Trends Table 12. AI Drug Discovery Industry Drivers Table 13. AI Drug Discovery Industry Opportunities and Challenges Table 14. AI Drug Discovery Industry Restraints Table 15. Global AI Drug Discovery Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global AI Drug Discovery Market Size by Region (2021-2026) & (US$ Million) Table 17. Global AI Drug Discovery Market Share by Region (2021-2026) Table 18. Global AI Drug Discovery Market Size by Region (2027-2032) & (US$ Million) Table 19. Global AI Drug Discovery Market Share by Region (2027-2032) Table 20. Global AI Drug Discovery Revenue by Players (US$ Million) & (2021-2026) Table 21. Global AI Drug Discovery Revenue Market Share by Players (2021-2026) Table 22. Global AI Drug Discovery Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global AI Drug Discovery Key Players Headquarters & Area Served Table 24. Global AI Drug Discovery Players, Product Type & Application Table 25. Global AI Drug Discovery Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global AI Drug Discovery by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global AI Drug Discovery Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global AI Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 30. Global AI Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 31. Global AI Drug Discovery Revenue Market Share by Type (2021-2026) Table 32. Global AI Drug Discovery Revenue Market Share by Type (2027-2032) Table 33. Global AI Drug Discovery Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global AI Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 35. Global AI Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 36. Global AI Drug Discovery Revenue Market Share by Application (2021-2026) Table 37. Global AI Drug Discovery Revenue Market Share by Application (2027-2032) Table 38. Recursion Company Information Table 39. Recursion Business Overview Table 40. Recursion AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Recursion AI Drug Discovery Product Portfolio Table 42. Recursion Recent Development Table 43. Insilico Medicine Company Information Table 44. Insilico Medicine Business Overview Table 45. Insilico Medicine AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Insilico Medicine AI Drug Discovery Product Portfolio Table 47. Insilico Medicine Recent Development Table 48. Schrödinger Company Information Table 49. Schrödinger Business Overview Table 50. Schrödinger AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Schrödinger AI Drug Discovery Product Portfolio Table 52. Schrödinger Recent Development Table 53. DeepMind Company Information Table 54. DeepMind Business Overview Table 55. DeepMind AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. DeepMind AI Drug Discovery Product Portfolio Table 57. DeepMind Recent Development Table 58. Insitro Company Information Table 59. Insitro Business Overview Table 60. Insitro AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Insitro AI Drug Discovery Product Portfolio Table 62. Insitro Recent Development Table 63. Generate Biomedicines Company Information Table 64. Generate Biomedicines Business Overview Table 65. Generate Biomedicines AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Generate Biomedicines AI Drug Discovery Product Portfolio Table 67. Generate Biomedicines Recent Development Table 68. XtalPi Company Information Table 69. XtalPi Business Overview Table 70. XtalPi AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. XtalPi AI Drug Discovery Product Portfolio Table 72. XtalPi Recent Development Table 73. Relay Therapeutics Company Information Table 74. Relay Therapeutics Business Overview Table 75. Relay Therapeutics AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Relay Therapeutics AI Drug Discovery Product Portfolio Table 77. Relay Therapeutics Recent Development Table 78. BenevolentAI Company Information Table 79. BenevolentAI Business Overview Table 80. BenevolentAI AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. BenevolentAI AI Drug Discovery Product Portfolio Table 82. BenevolentAI Recent Development Table 83. Roivant Sciences Company Information Table 84. Roivant Sciences Business Overview Table 85. Roivant Sciences AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Roivant Sciences AI Drug Discovery Product Portfolio Table 87. Roivant Sciences Recent Development Table 88. Ginkgo Bioworks Company Information Table 89. Ginkgo Bioworks Business Overview Table 90. Ginkgo Bioworks AI Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Ginkgo Bioworks AI Drug Discovery Product Portfolio Table 92. Ginkgo Bioworks Recent Development Table 93. Exscientia Company Information Table 94. Exscientia Business Overview Table 95. Exscientia AI Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Exscientia AI Drug Discovery Product Portfolio Table 97. Exscientia Recent Development Table 98. Merck KGaA Company Information Table 99. Merck KGaA Business Overview Table 100. Merck KGaA AI Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Merck KGaA AI Drug Discovery Product Portfolio Table 102. Merck KGaA Recent Development Table 103. Novartis Company Information Table 104. Novartis Business Overview Table 105. Novartis AI Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Novartis AI Drug Discovery Product Portfolio Table 107. Novartis Recent Development Table 108. Biotus Company Information Table 109. Biotus Business Overview Table 110. Biotus AI Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Biotus AI Drug Discovery Product Portfolio Table 112. Biotus Recent Development Table 113. Huazhi Bio Company Information Table 114. Huazhi Bio Business Overview Table 115. Huazhi Bio AI Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Huazhi Bio AI Drug Discovery Product Portfolio Table 117. Huazhi Bio Recent Development Table 118. MindRank AI Company Information Table 119. MindRank AI Business Overview Table 120. MindRank AI AI Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. MindRank AI AI Drug Discovery Product Portfolio Table 122. MindRank AI Recent Development Table 123. Ubigene Company Information Table 124. Ubigene Business Overview Table 125. Ubigene AI Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Ubigene AI Drug Discovery Product Portfolio Table 127. Ubigene Recent Development Table 128. WuXi AppTec Company Information Table 129. WuXi AppTec Business Overview Table 130. WuXi AppTec AI Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. WuXi AppTec AI Drug Discovery Product Portfolio Table 132. WuXi AppTec Recent Development Table 133. North America AI Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 134. North America AI Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 135. North America AI Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 136. North America AI Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 137. North America AI Drug Discovery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. North America AI Drug Discovery Revenue by Country (2021-2026) & (US$ Million) Table 139. North America AI Drug Discovery Revenue by Country (US$ Million) & (2027-2032) Table 140. Europe AI Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe AI Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe AI Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe AI Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe AI Drug Discovery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Europe AI Drug Discovery Revenue by Country (2021-2026) & (US$ Million) Table 146. Europe AI Drug Discovery Revenue by Country (US$ Million) & (2027-2032) Table 147. China AI Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 148. China AI Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 149. China AI Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 150. China AI Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia AI Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia AI Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia AI Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia AI Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia AI Drug Discovery Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia AI Drug Discovery Revenue by Region (US$ Million) & (2021-2026) Table 157. Asia AI Drug Discovery Revenue by Region (US$ Million) & (2027-2032) Table 158. SAMEA AI Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA AI Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA AI Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 161. SAMEA AI Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 162. SAMEA AI Drug Discovery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. SAMEA AI Drug Discovery Revenue by Country (2021-2026) & (US$ Million) Table 164. SAMEA AI Drug Discovery Revenue by Country (US$ Million) & (2027-2032) Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. AI Drug Discovery Image Figure 2. Global AI Drug Discovery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Discovery Market Size Share 2021 VS 2025 VS 2032 Figure 4. Machine Learning Type Image Figure 5. Deep Learning Type Image Figure 6. Natural Language Processing Type Image Figure 7. Data Mining Type Image Figure 8. Global AI Drug Discovery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global AI Drug Discovery Market Size Share 2021 VS 2025 VS 2032 Figure 10. Target Discovery and Validation Image Figure 11. Virtual Screening and Molecular Docking Image Figure 12. Drug Repurposing and Precision Medicine Image Figure 13. Clinical Data Analysis and Optimization Image Figure 14. Global AI Drug Discovery Market Size (US$ Million) & (2021-2032) Figure 15. Global AI Drug Discovery Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global AI Drug Discovery Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global AI Drug Discovery Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global AI Drug Discovery Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global AI Drug Discovery Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global AI Drug Discovery Revenue Market Share by Type (2021-2032) Figure 22. Global AI Drug Discovery Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global AI Drug Discovery Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global AI Drug Discovery Revenue Market Share by Application (2021-2032) Figure 25. North America AI Drug Discovery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America AI Drug Discovery Revenue Share by Type (2021-2032) Figure 27. North America AI Drug Discovery Revenue Share by Application (2021-2032) Figure 28. North America AI Drug Discovery Revenue Share by Country (2021-2032) Figure 29. United States AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe AI Drug Discovery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe AI Drug Discovery Revenue Share by Type (2021-2032) Figure 34. Europe AI Drug Discovery Revenue Share by Application (2021-2032) Figure 35. Europe AI Drug Discovery Revenue Share by Country (2021-2032) Figure 36. Germany AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China AI Drug Discovery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China AI Drug Discovery Revenue Share by Type (2021-2032) Figure 46. China AI Drug Discovery Revenue Share by Application (2021-2032) Figure 47. Asia AI Drug Discovery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia AI Drug Discovery Revenue Share by Type (2021-2032) Figure 49. Asia AI Drug Discovery Revenue Share by Application (2021-2032) Figure 50. Asia AI Drug Discovery Revenue Share by Region (2021-2032) Figure 51. Japan AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA AI Drug Discovery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA AI Drug Discovery Revenue Share by Type (2021-2032) Figure 59. SAMEA AI Drug Discovery Revenue Share by Application (2021-2032) Figure 60. SAMEA AI Drug Discovery Revenue Share by Country (2021-2032) Figure 61. Brazil AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt AI Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Machine Learning Type
  • Deep Learning Type
  • Natural Language Processing Type
  • Data Mining Type
Applications
  • Target Discovery and Validation
  • Virtual Screening and Molecular Docking
  • Drug Repurposing and Precision Medicine
  • Clinical Data Analysis and Optimization
Companies covered
  • Recursion
  • Insilico Medicine
  • Schrödinger
  • DeepMind
  • Insitro
  • Generate Biomedicines
  • XtalPi
  • Relay Therapeutics
  • BenevolentAI
  • Roivant Sciences
  • Ginkgo Bioworks
  • Exscientia
  • Merck KGaA
  • Novartis
  • Biotus
  • Huazhi Bio
  • MindRank AI
  • Ubigene
  • WuXi AppTec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Drug Discovery Market by Type
  3. 1.2.1 Global AI Drug Discovery Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Machine Learning Type
  5. 1.2.3 Deep Learning Type
  6. 1.2.4 Natural Language Processing Type
  7. 1.2.5 Data Mining Type
  8. 1.3 AI Drug Discovery Market by Application
  9. 1.3.1 Global AI Drug Discovery Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Target Discovery and Validation
  11. 1.3.3 Virtual Screening and Molecular Docking
  12. 1.3.4 Drug Repurposing and Precision Medicine
  13. 1.3.5 Clinical Data Analysis and Optimization
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 AI Drug Discovery Market Dynamics
  1. 2.1 AI Drug Discovery Industry Trends
  2. 2.2 AI Drug Discovery Industry Drivers
  3. 2.3 AI Drug Discovery Industry Opportunities and Challenges
  4. 2.4 AI Drug Discovery Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Drug Discovery Market Perspective (2021-2032)
  2. 3.2 Global AI Drug Discovery Growth Trends by Region
  3. 3.2.1 Global AI Drug Discovery Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Drug Discovery Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Drug Discovery Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Drug Discovery Revenue by Players
  2. 4.1.1 Global AI Drug Discovery Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Drug Discovery Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Drug Discovery Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Drug Discovery Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Drug Discovery Key Players Headquarters & Area Served
  7. 4.4 Global AI Drug Discovery Players, Product Type & Application
  8. 4.5 Global AI Drug Discovery Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Drug Discovery Market CR5 and HHI
  11. 4.6.3 2025 AI Drug Discovery Tier 1, Tier 2, and Tier 3
5 AI Drug Discovery Market Size by Type
  1. 5.1 Global AI Drug Discovery Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Drug Discovery Revenue by Type (2021-2032)
  3. 5.3 Global AI Drug Discovery Revenue Market Share by Type (2021-2032)
6 AI Drug Discovery Market Size by Application
  1. 6.1 Global AI Drug Discovery Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Drug Discovery Revenue by Application (2021-2032)
  3. 6.3 Global AI Drug Discovery Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Recursion
  2. 7.1.1 Recursion Company Information
  3. 7.1.2 Recursion Business Overview
  4. 7.1.3 Recursion AI Drug Discovery Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Recursion AI Drug Discovery Product Portfolio
  6. 7.1.5 Recursion Recent Developments
  7. 7.2 Insilico Medicine
  8. 7.2.1 Insilico Medicine Company Information
  9. 7.2.2 Insilico Medicine Business Overview
  10. 7.2.3 Insilico Medicine AI Drug Discovery Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Insilico Medicine AI Drug Discovery Product Portfolio
  12. 7.2.5 Insilico Medicine Recent Developments
  13. 7.3 Schrödinger
  14. 7.3.1 Schrödinger Company Information
  15. 7.3.2 Schrödinger Business Overview
  16. 7.3.3 Schrödinger AI Drug Discovery Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Schrödinger AI Drug Discovery Product Portfolio
  18. 7.3.5 Schrödinger Recent Developments
  19. 7.4 DeepMind
  20. 7.4.1 DeepMind Company Information
  21. 7.4.2 DeepMind Business Overview
  22. 7.4.3 DeepMind AI Drug Discovery Revenue and Gross Margin (2021-2026)
  23. 7.4.4 DeepMind AI Drug Discovery Product Portfolio
  24. 7.4.5 DeepMind Recent Developments
  25. 7.5 Insitro
  26. 7.5.1 Insitro Company Information
  27. 7.5.2 Insitro Business Overview
  28. 7.5.3 Insitro AI Drug Discovery Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Insitro AI Drug Discovery Product Portfolio
  30. 7.5.5 Insitro Recent Developments
  31. 7.6 Generate Biomedicines
  32. 7.6.1 Generate Biomedicines Company Information
  33. 7.6.2 Generate Biomedicines Business Overview
  34. 7.6.3 Generate Biomedicines AI Drug Discovery Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Generate Biomedicines AI Drug Discovery Product Portfolio
  36. 7.6.5 Generate Biomedicines Recent Developments
  37. 7.7 XtalPi
  38. 7.7.1 XtalPi Company Information
  39. 7.7.2 XtalPi Business Overview
  40. 7.7.3 XtalPi AI Drug Discovery Revenue and Gross Margin (2021-2026)
  41. 7.7.4 XtalPi AI Drug Discovery Product Portfolio
  42. 7.7.5 XtalPi Recent Developments
  43. 7.8 Relay Therapeutics
  44. 7.8.1 Relay Therapeutics Company Information
  45. 7.8.2 Relay Therapeutics Business Overview
  46. 7.8.3 Relay Therapeutics AI Drug Discovery Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Relay Therapeutics AI Drug Discovery Product Portfolio
  48. 7.8.5 Relay Therapeutics Recent Developments
  49. 7.9 BenevolentAI
  50. 7.9.1 BenevolentAI Company Information
  51. 7.9.2 BenevolentAI Business Overview
  52. 7.9.3 BenevolentAI AI Drug Discovery Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BenevolentAI AI Drug Discovery Product Portfolio
  54. 7.9.5 BenevolentAI Recent Developments
  55. 7.10 Roivant Sciences
  56. 7.10.1 Roivant Sciences Company Information
  57. 7.10.2 Roivant Sciences Business Overview
  58. 7.10.3 Roivant Sciences AI Drug Discovery Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Roivant Sciences AI Drug Discovery Product Portfolio
  60. 7.10.5 Roivant Sciences Recent Developments
  61. 7.11 Ginkgo Bioworks
  62. 7.11.1 Ginkgo Bioworks Company Information
  63. 7.11.2 Ginkgo Bioworks Business Overview
  64. 7.11.3 Ginkgo Bioworks AI Drug Discovery Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Ginkgo Bioworks AI Drug Discovery Product Portfolio
  66. 7.11.5 Ginkgo Bioworks Recent Developments
  67. 7.12 Exscientia
  68. 7.12.1 Exscientia Company Information
  69. 7.12.2 Exscientia Business Overview
  70. 7.12.3 Exscientia AI Drug Discovery Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Exscientia AI Drug Discovery Product Portfolio
  72. 7.12.5 Exscientia Recent Developments
  73. 7.13 Merck KGaA
  74. 7.13.1 Merck KGaA Company Information
  75. 7.13.2 Merck KGaA Business Overview
  76. 7.13.3 Merck KGaA AI Drug Discovery Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Merck KGaA AI Drug Discovery Product Portfolio
  78. 7.13.5 Merck KGaA Recent Developments
  79. 7.14 Novartis
  80. 7.14.1 Novartis Company Information
  81. 7.14.2 Novartis Business Overview
  82. 7.14.3 Novartis AI Drug Discovery Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Novartis AI Drug Discovery Product Portfolio
  84. 7.14.5 Novartis Recent Developments
  85. 7.15 Biotus
  86. 7.15.1 Biotus Company Information
  87. 7.15.2 Biotus Business Overview
  88. 7.15.3 Biotus AI Drug Discovery Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Biotus AI Drug Discovery Product Portfolio
  90. 7.15.5 Biotus Recent Developments
  91. 7.16 Huazhi Bio
  92. 7.16.1 Huazhi Bio Company Information
  93. 7.16.2 Huazhi Bio Business Overview
  94. 7.16.3 Huazhi Bio AI Drug Discovery Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Huazhi Bio AI Drug Discovery Product Portfolio
  96. 7.16.5 Huazhi Bio Recent Developments
  97. 7.17 MindRank AI
  98. 7.17.1 MindRank AI Company Information
  99. 7.17.2 MindRank AI Business Overview
  100. 7.17.3 MindRank AI AI Drug Discovery Revenue and Gross Margin (2021-2026)
  101. 7.17.4 MindRank AI AI Drug Discovery Product Portfolio
  102. 7.17.5 MindRank AI Recent Developments
  103. 7.18 Ubigene
  104. 7.18.1 Ubigene Company Information
  105. 7.18.2 Ubigene Business Overview
  106. 7.18.3 Ubigene AI Drug Discovery Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Ubigene AI Drug Discovery Product Portfolio
  108. 7.18.5 Ubigene Recent Developments
  109. 7.19 WuXi AppTec
  110. 7.19.1 WuXi AppTec Company Information
  111. 7.19.2 WuXi AppTec Business Overview
  112. 7.19.3 WuXi AppTec AI Drug Discovery Revenue and Gross Margin (2021-2026)
  113. 7.19.4 WuXi AppTec AI Drug Discovery Product Portfolio
  114. 7.19.5 WuXi AppTec Recent Developments
8 North America
  1. 8.1 North America AI Drug Discovery Revenue (2021-2032)
  2. 8.2 North America AI Drug Discovery Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Drug Discovery Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Drug Discovery Revenue by Type (2027-2032)
  5. 8.3 North America AI Drug Discovery Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Drug Discovery Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Drug Discovery Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Drug Discovery Revenue by Application (2027-2032)
  9. 8.5 North America AI Drug Discovery Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Drug Discovery Revenue by Country
  11. 8.6.1 North America AI Drug Discovery Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Drug Discovery Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Drug Discovery Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Drug Discovery Revenue (2021-2032)
  2. 9.2 Europe AI Drug Discovery Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Drug Discovery Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Drug Discovery Revenue by Type (2027-2032)
  5. 9.3 Europe AI Drug Discovery Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Drug Discovery Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Drug Discovery Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Drug Discovery Revenue by Application (2027-2032)
  9. 9.5 Europe AI Drug Discovery Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Drug Discovery Revenue by Country
  11. 9.6.1 Europe AI Drug Discovery Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Drug Discovery Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Drug Discovery Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Drug Discovery Revenue (2021-2032)
  2. 10.2 China AI Drug Discovery Revenue by Type (2021-2032)
  3. 10.2.1 China AI Drug Discovery Revenue by Type (2021-2026)
  4. 10.2.2 China AI Drug Discovery Revenue by Type (2027-2032)
  5. 10.3 China AI Drug Discovery Revenue Share by Type (2021-2032)
  6. 10.4 China AI Drug Discovery Revenue by Application (2021-2032)
  7. 10.4.1 China AI Drug Discovery Revenue by Application (2021-2026)
  8. 10.4.2 China AI Drug Discovery Revenue by Application (2027-2032)
  9. 10.5 China AI Drug Discovery Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Drug Discovery Revenue (2021-2032)
  2. 11.2 Asia AI Drug Discovery Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Drug Discovery Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Drug Discovery Revenue by Type (2027-2032)
  5. 11.3 Asia AI Drug Discovery Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Drug Discovery Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Drug Discovery Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Drug Discovery Revenue by Application (2027-2032)
  9. 11.5 Asia AI Drug Discovery Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Drug Discovery Revenue by Country
  11. 11.6.1 Asia AI Drug Discovery Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Drug Discovery Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Drug Discovery Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Drug Discovery Revenue (2021-2032)
  2. 12.2 SAMEA AI Drug Discovery Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Drug Discovery Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Drug Discovery Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Drug Discovery Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Drug Discovery Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Drug Discovery Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Drug Discovery Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Drug Discovery Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Drug Discovery Revenue by Country
  11. 12.6.1 SAMEA AI Drug Discovery Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Drug Discovery Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Drug Discovery Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst